Preformulation group - early biologic (mAb, diabodies, scFv, antibody drug conjugates) product characterization | Employed various analytical techniques to study the stability of various biologic formulations. Analysis included HPLC SEC, DLS, differential scanning calorimetry, differential scanning fluorimetry and nanoparticle tracking analysis. | Analyzed protein structure, stressed stability and molecule degradation profiles with the aim of formulating new biologics at higher concentrations with greater stability.
Developing solutions for companies looking to do business in a future with blockchains; helping to build a solid foundation for the polychain future.
iGEM, Collegate Nanoscience Society, ISC